Toggle navigation
Home
Search
Services
Blog
Contact
About
Biology of Cytokine-Induced Killer Cells
Lu, Peggy P.
Stanford University, Stanford, CA, United States
Search 8 grants from Peggy Lu
Search grants from Stanford University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The Resource of the MMRRC at UC Davis
Neuro HPA Project 1
Stanozolol in the Elderly with Venous Ulcers
Stereotypes, Shifting Standards, and Social Judgment
Training of Physicians in Occupational Medicine
Recently added grants:
Electroconvulsive therapy amplitude titration for improved clinical outcomes in late-life depression
Multi-atlas and whole body radiomics approaches for image-guided treatment of gynecologic cancers
A pilot study to define maintained alterations in mitochondrial DNA of eosinophilic esophagitis patients that may be exploited clinically
Managing Cardiac Toxicities of Cancer Therapy
Transendothelial Migration of Leukocytes: Developing New Paradigms in Health and Disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32CA009324-01
Application #
2085279
Study Section
Immunology, Virology, and Pathology Study Section (IVP)
Project Start
1993-04-01
Project End
Budget Start
1993-01-01
Budget End
1993-12-31
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Institution
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Related projects
NIH 1994
F32 CA
Biology of Cytokine-Induced Killer Cells
Lu, Peggy P. / Stanford University
NIH 1992
F32 CA
Biology of Cytokine-Induced Killer Cells
Lu, Peggy P. / Stanford University
Publications
Lu, P H; Negrin, R S
(1994)
A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.
J Immunol 153:1687-96
Comments
Be the first to comment on this grant